 |
Corporate News
13-Mar-25
|
|
|
|
|
|
|
|
|
|
|
|
Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
|
|
Due to mislabeling of infusion bag
|
|
|
|
|
|
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the United States.
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
|
|
|
|
Previous News |
Dr Reddys Laboratories allots 9,165 equity shares under ESOS
(
Corporate News
-
09-Dec-25
17:27
)
|
|
|
Dr Reddy’s Lab arm inks pact with Immutep SAS for novel cancer immunotherapy
(
Hot Pursuit
-
08-Dec-25
15:24
)
|
|
|
Dr Reddys Laboratories Ltd up for five straight sessions
(
Hot Pursuit
-
01-Dec-25
13:00
)
|
|
|
Dr Reddys Lab gains after securing EC nod for AVT03
(
Hot Pursuit
-
25-Nov-25
09:50
)
|
|
|
Dr. Reddy's receives EC marketing authorization for AVT03 (denosumab)
(
Corporate News
-
24-Nov-25
17:34
)
|
|
|
Dr Reddys Laboratories Ltd up for fifth session
(
Hot Pursuit
-
17-Nov-25
13:00
)
|
|
|
Dr Reddys Laboratories allots 7,430 equity shares under ESOS
(
Corporate News
-
13-Nov-25
14:59
)
|
|
|
Dr Reddys announces change in senior management
(
Corporate News
-
10-Nov-25
19:00
)
|
|
|
Dr. Reddy’s, Shaily Engineering tumble after delay in Semaglutide approval
(
Hot Pursuit
-
30-Oct-25
10:25
)
|
|
|
Dr Reddys Laboratories
(
Results
-
Analysis
25-Oct-25
12:51
)
|
|
|
Dr Reddys Lab Q2 PAT jumps 7% YoY to Rs 1,347 cr
(
Hot Pursuit
-
25-Oct-25
14:17
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|